ALLO financials

Allogene Therapeutics (ALLO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

ALLO income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$0.00–-$209.31M-$190.89M-0.87
2024$22.00K–-$273.20M-$257.59M-1.32
2023$95.00K–-$327.74M-$327.26M-2.09
2022$156.00K–-$335.54M-$340.41M-2.38
2021$114.09M–-$180.19M-$182.05M-1.34
2020$0.00–-$258.24M-$316.38M-2.63